Global Biodegradable Pharmaceutical Packaging Market Overview:
The packaging is one of the most integral parts of any pharmaceutical product. Pharmaceutical packaging is the process for pharmaceutical preparations. It includes all of the operations starting from the production through the drug distribution channels and then to the end consumer. The global biodegradable packaging market is expected to witness high demand due to rising consumer awareness regarding the environmental impact of packaging products and a willingness to replace packaging materials by alternatives with a lower carbon footprint. Some of the key players profiled in the study are Gerresheimer AG (Germany), Berry Plastics Corporation (United States), DS Smith PLC (United Kingdom), Klabin SA (Brazil), Rengo Co. Ltd (Japan), Bemis Company Inc. (United States), Smurfit Kappa Group PLC (Ireland) and Amcor Limited (Australia).
On the basis of geography, the market of Biodegradable Pharmaceutical Packaging has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Packaging Type, the sub-segment i.e. Cartons will boost the Biodegradable Pharmaceutical Packaging market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- growing pharmaceutical industry most notably in several emerging economies
- growing demand for convenient packaging types
- Government Support For the Biodegradable Packaging
- Unavailability of Raw Material for Packaging
- Growing R&D Investments Leading to Increased Pharmaceutical Productions
- Emerging Demand for Eco-Friendly Packaging across the World
- Growing Investments for Non-biodegradable and Recyclable Packaging Solutions
FDA Regulation: Subpart G of 21 Code of Federal Regulations Part 211- Subpart G of the regulations includes the criteria for examining and using materials, issuing labels, using tamper-evident packaging for over-the-counter drugs, conducting packaging and labeling operations, inspecting drug products, and assigning an expiration date. Also, manufacturers should have written procedures that ensure the correct labeling and packaging is used for a given drug product.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Target Audience:Manufacturers of Biodegradable Pharmaceutical Packaging, Suppliers and Distributors of Biodegradable Pharmaceutical Packaging Materials, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Biodegradable Pharmaceutical Packaging market on the basis of product [Plastic [Starch-Based Plastics, Cellulose-Based Plastics, Polylactic Acid (PLA), Polyhydroxyalkanoates (PHA), Other] and Paper] , application [Pharmaceutical Firms, Biotechnological Firms and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Biodegradable Pharmaceutical Packaging market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Biodegradable Pharmaceutical Packaging industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Biodegradable Pharmaceutical Packaging market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.